Skip to content
Parakho

Shelter Pharma Ltd

BSE 543963

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Q4 FY26

Shelter Pharma reported FY26 revenue from operations of Rs 73.13 crore, up 44% year-on-year, with EBITDA of Rs 12.72 crore and PAT of Rs 9.03 crore. Management said exports grew 164% to around Rs 6 crore and that veterinary contributed 55% of revenue against 45% from human healthcare. The company outlined plans for a second manufacturing facility near Ahmedabad and set a long-term revenue target of around Rs 200 crore by FY2030.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Filings

12 shown · 61 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 10 Oct 2026.